LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ: LABT · HEALTHCARE · BIOTECHNOLOGY
$2.95
-4.60% today
Updated 2026-06-02
Market cap
$6.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.26
Dividend yield
—
52W range
$1 – $10
Volume
2.5M
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item |
|---|
| Revenue |
| Revenue growth (YoY) |
| Cost of revenue |
| Gross profit |
| Gross margin |
| R&D |
| SG&A |
| Operating income |
| Operating margin |
| EBITDA |
| EBITDA margin |
| EBIT |
| Interest expense |
| Income tax |
| Effective tax rate |
| Net income |
| Net income growth (YoY) |
| Profit margin |